Literature DB >> 22532630

Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.

M van den Broek1, L Dirven, J K de Vries-Bouwstra, A J Dehpoor, Y P M Goekoop-Ruiterman, A H Gerards, P J S M Kerstens, T W J Huizinga, Wf Lems, C F Allaart.   

Abstract

OBJECTIVE: Several prediction models for rapid radiological progression (RRP) in the first year of rheumatoid arthritis have been designed to aid rheumatologists in their choice of initial treatment. The association was assessed between RRP and disability and joint damage progression in 8 years.
METHODS: Patients from the BeSt cohort were used. RRP was defined as an increase of ≥5 points in the Sharp/van der Heijde score (SHS) in year 1. Functional ability over 8 years, measured with the health assessment questionnaire (HAQ), was compared for patients with and without RRP using linear mixed models. Joint damage progression from years 1 to 8 was compared using logistic regression analyses.
RESULTS: RRP was observed in 102/465 patients. Over 8 years, patients with RRP had worse functional ability: difference in HAQ score 0.21 (0.14 after adjustment for disease activity score (over time)). RRP was associated with joint damage progression ≥25 points in SHS in years 1-8: OR 4.6.
CONCLUSION: RRP in year 1 is a predictor of worse functional ability over 8 years, independent of baseline joint damage and disease activity. Patients with RRP have more joint damage progression in subsequent years. RRP is thus a relevant outcome on which to base the initial treatment decision.

Entities:  

Mesh:

Year:  2012        PMID: 22532630     DOI: 10.1136/annrheumdis-2011-201212

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  Imaging: Use of MRI as an outcome measure in clinical trials in RA.

Authors:  Annette H M van der Helm-van Mil
Journal:  Nat Rev Rheumatol       Date:  2012-10-16       Impact factor: 20.543

Review 2.  Rheumatoid arthritis--early diagnosis and disease management.

Authors:  Matthias Schneider; Klaus Krüger
Journal:  Dtsch Arztebl Int       Date:  2013-07-08       Impact factor: 5.594

Review 3.  Damage assessment in ANCA-associated vasculitis.

Authors:  Kuljeet Bhamra; Raashid Luqmani
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

4.  Predictive factors of radiological progression after 2 years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study.

Authors:  Gülşah Akdemir; Marije K Verheul; Lotte Heimans; Kirsten V C Wevers-de Boer; Yvonne P M Goekoop-Ruiterman; Maikel van Oosterhout; Joop B Harbers; Casper Bijkerk; Gerda M Steup-Beekman; Leroy R Lard; Tom W J Huizinga; Leendert A Trouw; Cornelia F Allaart
Journal:  RMD Open       Date:  2016-02-15

5.  Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort.

Authors:  Raphaèle Seror; Saida Boudaoud; Stephan Pavy; Gaetane Nocturne; Thierry Schaeverbeke; Alain Saraux; Philippe Chanson; Jacques-Eric Gottenberg; Valérie Devauchelle-Pensec; Gabriel J Tobón; Xavier Mariette; Corinne Miceli-Richard
Journal:  Sci Rep       Date:  2016-01-20       Impact factor: 4.379

6.  Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis.

Authors:  Charlotte Hua; Claire I Daien; Bernard Combe; Robert Landewe
Journal:  RMD Open       Date:  2017-01-05

7.  Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis.

Authors:  Xiao-Xiang Chen; Wolfgang Baum; Denise Dwyer; Michael Stock; Kay Schwabe; Hua-Zhu Ke; Marina Stolina; Georg Schett; Aline Bozec
Journal:  Ann Rheum Dis       Date:  2013-05-10       Impact factor: 19.103

8.  Smoking in combination with antibodies to cyclic citrullinated peptides is associated with persistently high levels of survivin in early rheumatoid arthritis: a prospective cohort study.

Authors:  Björn Svensson; Ingiäld Hafström; Malin C Erlandsson; Kristina Forslind; Maria I Bokarewa
Journal:  Arthritis Res Ther       Date:  2014-01-16       Impact factor: 5.156

9.  Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).

Authors:  Lotte Heimans; Gülşah Akdemir; Kirsten V C Wevers-de Boer; Yvonne P Goekoop-Ruiterman; Esmeralda T Molenaar; Johannes H L M van Groenendael; Andreas J Peeters; Gerda M Steup-Beekman; Leroy R Lard; Peter B J de Sonnaville; Bernard A M Grillet; Tom W J Huizinga; Cornelia F Allaart
Journal:  Arthritis Res Ther       Date:  2016-01-21       Impact factor: 5.156

10.  Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.

Authors:  Benjamin Granger; Bernard Combe; Xavier Le Loet; Alain Saraux; Francis Guillemin; Bruno Fautrel
Journal:  RMD Open       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.